Today: 10 July 2026
Browse Category

Stock Market 12 May 2026

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Therapeutics shot higher on Tuesday, though the trading action left plenty of questions. The move was really a textbook biotech squeeze, sparked by fresh investor focus on ERNA-101, their preclinical cell therapy for ovarian cancer. The stock’s thin float and last month’s reverse split set the stage. As of 3:50 p.m. ET, shares were changing hands at $11.43, marking a gain of 58.5%. ERNA swung as high as $15.58, with an intraday floor at $6.86.
12 May 2026
··
BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

BuzzFeed shares surged Tuesday after Byron Allen’s family office struck a deal to buy 40 million Class A shares at $3 apiece, putting Allen Family Digital on track for roughly 52% control—and setting up Allen to take over as chairman and CEO. The jump was dramatic: Reuters reported the stock soared around 156% in after-hours trade on the news, then cooled off but held onto massive gains as Tuesday’s session unfolded.
12 May 2026
·
Terns Pharmaceuticals stock stops trading as Merck’s $53 cash deal takes over the chart

Terns Pharmaceuticals stock stops trading as Merck’s $53 cash deal takes over the chart

Terns Pharmaceuticals shares aren’t budging—not surprising, since the merger is done and Nasdaq trading is finished. The last quote for the stock came in at $52.95, just shy of Merck’s $53-per-share cash deal. With Terns now fully absorbed into Merck, its common stock has dropped off the Nasdaq Global Select Market and won’t trade again.
12 May 2026
····
Archer Aviation Stock Drops as FAA Progress Runs Into Cash-Burn Math

Archer Aviation Stock Drops as FAA Progress Runs Into Cash-Burn Math

Shares of Archer Aviation dropped hard Tuesday, now changing hands at $6.11, down roughly 6.6%. Even with a positive regulatory update, investors zeroed in on the company’s still-sizeable capital requirements before it can convert flight trials into commercial operations. The price swung throughout the session—opening at $6.34, touching $6.66, and sliding toward $6.06.
12 May 2026
·
RKLB Stock Pulls Back After Breakout as Neutron Demand Starts to Set the Price

RKLB Stock Pulls Back After Breakout as Neutron Demand Starts to Set the Price

Rocket Lab shares pulled back on Tuesday, giving back some ground after their sharp climb to new highs. The action didn’t point to a big shift in sentiment—buyers continued snapping up shares on weakness, even as some holders locked in gains after the post-earnings surge. Both sides stayed active, but the day’s drop looked more like a pause than a reversal in RKLB’s trajectory.
12 May 2026
···
1 … 197 198 199 200 201 … 1,635

Stock Market Today

  • James Hardie Industries (NYSE:JHX) Sinks 5.3% After Russell Growth Indices Cut
    July 10, 2026, 4:15 PM EDT. James Hardie Industries plc (NYSE:JHX) dropped 5.3% after being cut from major Russell growth indices as of June 27, 2026. Losing its slot means less ownership by index-tracker funds and could make the stock price more volatile. The main reasons to stay invested, including fiber cement and AZEK growth and an expected $6.3 billion in 2029 sales, are still on the table. But pressure on profit margins, higher debt loads, and refinancing risks are concerns, especially with housing looking soft. The company booked $4.84 billion in revenue, but net income was down at $104 million in May 2026. Analyst views on value remain mixed, as housing cycle and integration bumps hold back bulls.
Go toTop